Harvard Bioscience Ownership | Who Owns Harvard Bioscience?

Overview Forecast RevenueFinancials Chart Transcripts

Harvard Bioscience Ownership Summary

Harvard Bioscience is owned by 35.16% institutional investors, 7.23% insiders, and 57.62% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.84% of HBIO shares. Harvey Partners Small-Cap Opportunity is the top mutual fund, with 5.12% of its assets in Harvard Bioscience shares.

HBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Harvard Bioscience	35.16%	7.23%	57.62%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Medical Instruments & Supplies Stocks	46.11%	12.95%	40.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.98M	6.84%	$6.29M
Blackrock	2.84M	6.55%	$8.10M
Punch & associates investment management	2.77M	6.39%	$7.90M
Harvey partners	2.68M	6.15%	$5.66M
Amh equity	2.50M	5.73%	$5.28M
Vanguard group	2.16M	4.95%	$4.55M
Royce & associates lp	1.97M	4.51%	$4.15M
Granahan investment management	1.93M	4.44%	$5.49M
Dimensional fund advisors lp	1.67M	3.82%	$3.51M
B. riley asset management	1.35M	3.10%	$2.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Amh equity	2.50M	5.19%	$5.28M
B. riley asset management	1.35M	2.70%	$2.85M
Acuitas investments	491.09K	0.85%	$1.04M
Meros investment management, lp	813.71K	0.77%	$1.72M
Harvey partners	2.68M	0.63%	$5.66M
Punch & associates investment management	2.77M	0.46%	$7.90M
Granahan investment management	1.93M	0.22%	$5.49M
Williams & novak	99.21K	0.20%	$209.33K
Bard associates	267.70K	0.19%	$564.85K
Heartland advisors	1.20M	0.14%	$2.53M

Top Buyers

Holder	Shares	% Assets	Change
Royce & associates lp	1.97M	0.04%	513.66K
Acadian asset management	998.79K	0.01%	125.18K
Amh equity	2.50M	5.19%	111.13K
Williams & novak	99.21K	0.20%	99.21K
Gamco investors, inc. et al	95.00K	0.00%	95.00K

Top Sellers

Holder	Shares	% Assets	Change
Russell investments group	2.92K	-	-298.30K
Archon capital management	-	-	-260.86K
Boston partners	-	-	-207.33K
Boothbay fund management	1.15M	0.06%	-184.42K
B. riley asset management	1.35M	2.70%	-184.42K

New Positions

Holder	Shares	% Assets	Change	Value
Williams & novak	99.21K	0.20%	99.21K	$209.33K
Susquehanna group, llp	35.46K	-	35.46K	$74.81K
Virtu financial	35.39K	0.01%	35.39K	$101.00K
Sei investments	22.27K	0.00%	22.27K	$46.98K
Cubist systematic strategies	14.14K	0.00%	14.14K	$40.31K

Sold Out

Holder	Change
Capital performance advisors llp	-41.00
Qube research	-56.00
Ronald blue trust	-78.00
Massmutual trust co fsb/adv	-271.00
Clear street markets	-310.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	45	-52.63%	15,332,661	-50.99%	35	0.68%	26	-42.22%	8	-70.37%
Sep 30, 2024	95	-5.94%	30,343,546	-4.61%	69	1.30%	45	-26.23%	28	7.69%
Jun 30, 2024	101	12.22%	31,809,122	-2.15%	73	1.31%	61	79.41%	26	-35.00%
Mar 31, 2024	90	-4.26%	32,508,345	-1.43%	74	1.24%	34	-12.82%	40	37.93%
Dec 31, 2023	94	-4.08%	32,980,745	0.14%	77	1.31%	39	-18.75%	29	3.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Harvey Partners Small-Cap Opportunity	2.23M	5.12%	-31.84K
Vanguard US Total Market Shares ETF	1.26M	2.86%	-
Vanguard Total Stock Mkt Idx Inv	1.26M	2.86%	-
Heartland Value Investor	1.20M	2.72%	-
iShares Russell 2000 ETF	970.63K	2.20%	-8.41K
Royce Micro Cap Trust	872.05K	2.00%	513.66K
Acuitas US Microcap Strategy	682.85K	1.57%	-
Royce Micro-Cap Invmt	647.02K	1.48%	-
Vanguard Institutional Extnd Mkt Idx Tr	579.99K	1.32%	-
Granahan SC Advantage	453.80K	1.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 13, 2024	Green James W	Chief Executive Officer	Buy	$29.10K
Jun 06, 2024	Green James W	Chief Executive Officer	Buy	$61.40K
Aug 17, 2023	Green James W	Chief Executive Officer	Buy	$109.50K
Mar 14, 2023	EDRICK ALAN I	-	Buy	$36.87K
Mar 15, 2023	EDRICK ALAN I	-	Buy	$42.42K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	2	-
2024 Q1	-	-
2023 Q4	-	-

HBIO Ownership FAQ

Who Owns Harvard Bioscience?

Harvard Bioscience shareholders are primarily institutional investors at 35.16%, followed by 7.23% insiders and 57.61% retail investors. The average institutional ownership in Harvard Bioscience's industry, Medical Instruments & Supplies Stocks, is 46.11%, which Harvard Bioscience falls below.

Who owns the most shares of Harvard Bioscience?

Harvard Bioscience’s largest shareholders are Blackrock funding, inc. /de (2.98M shares, 6.84%), Blackrock (2.84M shares, 6.55%), and Punch & associates investment management (2.77M shares, 6.39%). Together, they hold 19.78% of Harvard Bioscience’s total shares outstanding.

Does Blackrock own Harvard Bioscience?

Yes, BlackRock owns 6.55% of Harvard Bioscience, totaling 2.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.1M$. In the last quarter, BlackRock increased its holdings by 9.99K shares, a 0.35% change.

Who is Harvard Bioscience’s biggest shareholder by percentage of total assets invested?

Amh equity is Harvard Bioscience’s biggest shareholder by percentage of total assets invested, with 5.19% of its assets in 2.5M Harvard Bioscience shares, valued at 5.28M$.

Who is the top mutual fund holder of Harvard Bioscience shares?

Harvey Partners Small-Cap Opportunity is the top mutual fund holder of Harvard Bioscience shares, with 5.12% of its total shares outstanding invested in 2.23M Harvard Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools